Newsroom

Nov 04, 2021

Orca Bio to Present New Clinical Data on Orca-T at the 63rd American Society of Hematology Annual Meeting

View

Feb 11, 2021

Orca Bio Announces Updated Orca-T Clinical Data Presented at the 2021 TCT (Transplantation & Cellular Therapy) Meetings of the American Society of Transplantation and Cellular Therapy (ASTCT) and Center for International Blood & Marrow Transplant Research (CIBMTR)

View

Jan 06, 2021

Orca Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference

View

Dec 06, 2020

First Clinical Data From Ongoing Orca-T Trial Shows Significantly Improved 12-Month Graft Versus Host Disease (GvHD)-Free and Relapse-Free Survival (GRFS) in Blood Cancer Patients Receiving a Hematopoietic Stem Cell Transplant (HSCT)

View

Nov 04, 2020

Orca Bio Announces Oral Presentation of Orca-T Clinical Data at the 62nd American Society of Hematology (ASH) Annual Meeting

View

Oct 14, 2020

Orca Bio Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for Orca-T

View

Sep 02, 2020

Orca Bio and Lyell Immunopharma Announce Research Partnership

View

Jun 17, 2020

Orca Bio Emerges With Nearly $300 Million to Transform Allogeneic Cell Therapy

View